Market Synopsis

According to Market Research Future (MRFR), the global small molecule API market is anticipated to acquire the market value of USD 279,687.1 million, expanding at a CAGR of 7% during the projection period from 2016 to 2027.

Get Sample Report:

The small molecule active pharmaceutical ingredient is projected to gain traction owing to their strong therapeutic effect with a small dose at a lower cost of administration. The increasing incidences of chronic diseases such as cancer, cardiovascular, and others are anticipated to be a key factor in driving the small molecule api market 2020. Furthermore, various applications of small molecule API in pesticides, cell signalling molecules can increase its demand and grow the market during the evaluation period. In recent years, there has been a rising awareness in the major worldwide population regarding their health and advantages of small molecule API. In addition, the increasing technological development in the manufacturing sector are anticipated to fuel the market growth in the review period.

On the contrary, stringent regulatory requirements can impede the market growth. However, the developing pharmaceutical industry, along with above mentioned factors, are predicted to counter the hampering factors and boost the market.

Key Players

Some of the renowned names of the Small Molecule API Market are

  • Albemarle Corporation,
  • Allergan Plc,
  • Aurobindo Pharma,
  • Cambrex Corporation,
  • Reddy’s Laboratories Ltd,
  • GlaxoSmithKline Plc,
  • Lonza, Mylan N.V.,
  • Pfizer Inc.,
  • Merck Sharp & Dohme Corp.,
  • Novartis AG,
  • Teva Pharmaceutical Industries Ltd.,
  • Siegfried AG, and
  • Sun Pharmaceutical Industries Ltd.

Market Segmentation

The segmental analysis of the global small molecule API market is done by application, type, and manufacturing methods.

  • The application-based segments of the small molecule API market are cardiovascular, oncology, diabetes, and immunological disorders. Among all, the cardiovascular segment is predicted to procure the maximum market share during the evaluation period.
  • The type-based segments of the global small molecule API market are synthetic/chemical API and biological API. Among all, the synthetic/chemical API segment is predicted to acquire the largest market share during the review period.
  • The manufacturing methods-based segments of the global small molecule API market are in-house manufacturing (Captive) and contract manufacturing (CMO). Among all, the in-house manufacturing segment is anticipated to acquire the maximum CAGR.

Regional Analysis

On the basis of region, the global market is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.

As per the analysis, the global small molecule API by acquiring the largest market share during the forecast period. The regional market growth can be attributed to the significant participation of the key players present in the region. Furthermore, the growing healthcare development is projected to be another cause leading to the regional market expansion. Among all, the US and Canada are anticipated to make substantial participation in developing the regional market during the forecast period.

Europe market is anticipated to acquire the second largest market share during the forecast period owing to the increasing R&D programs. As per the analysis, Germany is likely to dominate the regional market due to the increased initiatives taken to support generic drug growth with pricing reimbursement.

APAC region is projected to expand at the fastest rate during the forecast period owing to the rapid rise in the population. Furthermore, emerging economies like India and China are anticipated to make a significant contribution by taking initiatives to develop the healthcare infrastructure.

The MEA region is anticipated to witness sluggish market growth due to less exposure to health care services. However, the presence of untapped opportunities may expand the market in the coming period.

Browse Full Report:

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013